A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine

Table 4 Average Daily Weight gain improvement/reduction between treatment groups over the finishing period and overall (* p = 0.0004 **p = 0.0014)

Compared groups	ADWG over the finishing period (g/d)	Reduction of ADWG over the finishing period	Wean-to-finish ADWG (g/d)	Reduction of ADWG from wean-to-finish
PCVM vs. NC	PCVM: 842	−38 g/day* and 95% CI [−57, −19]	PCVM: 660	−24 g/day** and 95% CI [−37, −11]
PCVM vs. NC	NC: 803	−38 g/day* and 95% CI [−57, −19]	NC: 634	−24 g/day** and 95% CI [−37, −11]
FLEX vs. NC	FLEX: 827	−26 g/day* and 95% CI [−44, −7]	FLEX: 650	−17 g/day** and 95% CI [−30, −3]
FLEX vs. NC	NC: 803	−26 g/day* and 95% CI [−44, −7]	NC: 634	−17 g/day** and 95% CI [−30, −3]
PCVM vs. FLEX	PCVM: 842	−12 g/day and 95% CI [−31, 7]	PCVM: 660	−8 g/day and 95% CI [−21, 6]
PCVM vs. FLEX	FLEX: 827	−12 g/day and 95% CI [−31, 7]	FLEX: 650	−8 g/day and 95% CI [−21, 6]

ISSN: 2055-5660